Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Mitochondrial Complex Enzyme Activities and Cytochrome c Expression Changes in Multiple Sclerosis.
Chromatin Landscape Defined by Repressive Histone Methylation during Oligodendrocyte Differentiation.
Water Extract from the Leaves of Withania somnifera Protect RA Differentiated C6 and IMR-32 Cells against Glutamate-Induced Excitotoxicity.
Retinal thickness in pediatric multiple sclerosis.
Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis.
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.
Voiding dysfunction in patients with neuromyelitis optica spectrum disorders.
Morning glory syndrome associated with multiple sclerosis.
Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis.
Genetic control of nerve conduction velocity may influence multiple sclerosis phenotype.
Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis.
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
A dorsiflexion assist orthosis reduces the physiological cost and mitigates deterioration in strength and balance associated with walking in people with Multiple Sclerosis.
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study.
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
[The process of meaning-making in adjustment to multiple sclerosis.]
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.
Interleukin-6 control of early Theiler's Murine Encephalomyelitis Virus replication in macrophages occurs in conjunction with STAT1 activation and nitric oxide production.
Predicting short-term conversion from CIS to MS: Relevance of lesion distribution.
Social support, depression, and physical disability: Age and diagnostic group effects.
Epigenetics in NG2 glia cells.
Detecting clinically-relevant changes in progressive multiple sclerosis.
The prevalence of incidental findings in multiple sclerosis patients.
Pages
« first
‹ previous
…
277
278
279
280
281
282
283
284
285
…
next ›
last »